Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 600-026-8 | CAS number: 1000817-22-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- yes
Test material
- Reference substance name:
- Fatty acids, C8-18 and C18-unsatd., reaction products with diethanolamine and propylene oxide
- EC Number:
- 600-026-8
- Cas Number:
- 1000817-22-0
- Molecular formula:
- Unspecified
- IUPAC Name:
- Fatty acids, C8-18 and C18-unsatd., reaction products with diethanolamine and propylene oxide
- Details on test material:
- - Name of test material (as cited in study report): Kerocom FM 38
- Physical state: liquid, yellow, clear
- Analytical purity: 99.2%
- Lot/batch No.: 2011285
- Storage condition of test material: ambient
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories
- Age at study initiation: 10-11 weeks
- Fasting period before study: no
- Housing: During overnight matings, male and female mating partners were housed together in Makrolon type M III cages. Pregnant animals and their litters were housed together until PND 4
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: yes
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 30-70%
- Air changes (per hr): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- Kerocom FM 38 was applied as a solution. To prepare this solution, the appropriate amount of test substance was weighed out depending on the desired concentration. Then, drinking water was filled up to the desired volume, subsequently released with a magnetic stirrer. The test substance preparations were produced at least once a week. The administration volume was 10 mL/kg body weight.
- Details on mating procedure:
- - M/F ratio per cage: 1 male and 1 female
- Length of cohabitation: mating occured overnight until sperm in vaginal smear was detected
- Proof of pregnancy:sperm in vaginal smear; referred to as day 0 of pregnancy
- After successful mating each pregnant female was caged: alone - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The stability of the test substance in drinking water was demonstrated over a period of 7 days at room temperature. As the mixtures were stored no longer than this time period, the stability was guaranteed
- Duration of treatment / exposure:
- 2-week pre-mating and mating period in both sexes, at least 3 days post-mating in males, and the entire gestation period as well as 4 days of lactation and two weeks thereafter in females
- Frequency of treatment:
- daily
- Details on study schedule:
- After 2 weeks of premating treatment, the F0 animals were mated to produce F1 generation pups. Mating pairs were from the same test group. Mating was discontinued as soon as sperm was detected in the vaginal smear. F0 animals were examined for their reproductive performance including determination of the number of implantation sites and the calculation of postimplantation loss for all F0 females. Furthermore, examinations as mentioned below were performed
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 100, 300, 1000 mg/kg/d
Basis:
actual ingested
- No. of animals per sex per dose:
- 10 M/F
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- The oral route was selected since this was proven to be suitable for the detection of a toxicological hazard.
- Positive control:
- No
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Cage side observations: A cageside examination was conducted at least once daily for any signs of morbidity, pertinent behavioral changes and signs of overt toxicity. Abnormalities and changes were documented daily for each affected animal.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Detailed clinical observations (DCO) were performed in all animals prior to the administration period and thereafter at weekly intervals.
BODY WEIGHT: Yes
- Time schedule for examinations: Body weight was determined before the start of the administration period in order to randomize the animals. During the administration period body weight was determined on study day 0 (start of the administration period) and thereafter once a week at the same time of the day (in the morning).
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
Generally, food consumption was determined once a week for male and female parental animals,
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes / No / No data
Drinking water consumption was monitored by daily visual inspection of the water bottles for any changes in volume. - Litter observations:
- PARAMETERS EXAMINED
The following parameters were examined in F1 offspring: number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities - Postmortem examinations (parental animals):
- All parental animals were sacrificed by decapitation under isoflurane anesthesia. The exsanguinated animals were necropsied and assessed by gross pathology, special attention being given to the reproductive organs.
HISTOPATHOLOGY / ORGAN WEIGHTS
The following organs or tissues were fixed in 4% buffered formaldehyde solution or in modified Davidson’s solution:
1. All gross lesions
2. Cervix
3. Coagulating glands
4. Epididymides (modified Davidson’s solution)
5. Ovaries (modified Davidson’s solution)
6. Oviducts
7. Prostate gland
8. Seminal vesicles
9. Testes (modified Davidson’s solution)
10.Vagina
11.Uterus - Postmortem examinations (offspring):
- All surviving pups (sacrificed on PND 4 under isoflurane anesthesia with CO2), all stillborn pups and those pups, which died ahead of schedule, were examined externally, eviscerated and their organs were assessed macroscopically.
- Statistics:
- DUNNETT-test (Food consumption)
FISHER'S EXACT-test (mating indices, fertility indices, gestation index, females with liveborn pups, females with stillborn pups, females with all stillborn pups, live birth index, pups stillborn, pups died, pups cannibalized)
WILCOXON-test (Number of mating days) - Reproductive indices:
- Were calculated (see below)
- Offspring viability indices:
- Were calculated (see below)
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Other effects:
- not specified
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- effects observed, treatment-related
Details on results (P0)
Female animal No. 122 of test group 2 (300 mg/kg bw/d) was sacrificed moribund on study day 14 (mating day 1).
No other animals died or were sacrificed moribund during the study period.
Salivation following treatment was observed (with increasing concentrations of the test item).
BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS)
No treatment-related changes in food consumption and body weights were observed.
REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
The male mating index was 100% in test groups 0 (0 mg/kg bw/d; control group) and 1 (100 mg/kg bw/d) and 90% in test groups 2 (300 mg/kg bw/d) and 3 (1000 mg/kg bw/d). The male fertility indices were 100% in test group 0, 90% in groups 1 and 2 and 70% in group 3.
The female mating index calculated after the mating period for F1 litter was 100% for test groups 0 and 1 and 90% for test groups and 3 (1000 mg/kg bw/d). The mean duration until sperm was detected (GD 0) was 3.4, 2.7, 2.7 and 2.9 days in test groups 0-3. The female fertility index was 100% in test groups 0 and 2, 90% in group 1 and 2 and 77.8% in group 3. The gestation index was 100% in all test groups. The postimplantation loss was not significantly changed when test groups 1-3 were compared to the control animals.
The rate of liveborn pups was 99.1% in test group 0 (control group) and 100% in all treatment test groups
ORGAN WEIGHTS (PARENTAL ANIMALS)
All mean absolute and relative weight parameters showed no significant differences when compared to the control group 0.
GROSS PATHOLOGY (PARENTAL ANIMALS)
All macroscopic findings occurred either individually or were biologically equally distributed over control and treatment groups. They were considered to be incidental or spontaneous in origin and without any relation to treatment.
HISTOPATHOLOGY (PARENTAL ANIMALS)
No relevant alterations were seen in the genital organs of male and female rats with failing offspring in test group 3 (1000 mg/kg bw/d). All findings occurred either individually or were biologically equally distributed over control and treatment groups. They were considered to be incidental or spontaneous in origin and without any relation to treatment.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Remarks:
- systemic
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no relevant effects observed
- Dose descriptor:
- NOAEL
- Remarks:
- reproductive performance, fertility and development
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no relevant effects observed
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- effects observed, treatment-related
- Mortality / viability:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- effects observed, treatment-related
- Histopathological findings:
- not examined
Details on results (F1)
Only one stillborn pup was seen in animal No. 107 of test group 0, so the rate of liveborn pups was 99.1% in test group 0 (control group) and 100 % in all treatment test groups.
The mean number of delivered F1 pups per dam was evenly distributed among the test groups. The number of delivered F1 pups was 109 in test groups 0 (control group), 1 (100 mg/kg bw/d) and 2 (300 mg/kg bw/d) and 70 in test group 3 (1000 mg/kg bw/d).
CLINICAL SIGNS (OFFSPRING)
The surviving F1 pups of any test group did not show adverse clinical signs up to scheduled sacrifice on PND 4.
The sex distribution and sex ratios of live F1 pups on the day of birth and PND 4 did not show substantial differences between the control and the test substance-treated groups
BODY WEIGHT (OFFSPRING)
Mean body weight of male pups in test group 3 (1000 mg/kg bw/d) was significantly increased on PND 1 (+17%) and 4 (+16%). Thus, the body weight of male and female pups was also significantly increased on PND 1 (+16%) and 4 (+17%). These changes were assessed as being incidental and not related to treatment. No differences in body weight change data were observed.
GROSS PATHOLOGY (OFFSPRING)
No test substance-related findings were observed.
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no relevant effects observed
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.